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background: Although elderly patients are at a higher risk for coronary artery disease, these patients are under-represented in landmark clinical 
trials. The aim of this study was to evaluate the long term efficacy and safety of drug eluting stents (DES) compared to bare metal stents (BMS) in 
octogenarians and nonagenarians undergoing coronary stenting.
Methods: In a single center prospective observational registry, 516 octogenarians and nonagenarians underwent successful coronary stenting from 
‘01-’12. Post procedural outcomes [all-cause mortality, major adverse cardioascular events (MACE) and bleeding events] were compared between 
those receiving DES and BMS groups.
results: Mean follow-up duration was 3.3±2 years. Mean age was 83 ± 3yrs and 84 ± 3yrs for DES and BMS respectively. After adjusting by 
multivariate analysis for differences in baseline, clinical and angiographic characteristics, DES use was an independent predictor of lower target 
vascular revascularization (TVR) (7% versus 11%, adjusted odds ratio (OR)=0.45, 95% CI=0.23-0.89, p=0.021), lower MACE (37% versus 51%, 
adjusted OR=0.61, 95% CI=0.42-0.90, p=0.013) and a trend towards lower mortality (30% versus 40%, adjusted OR=0.72 95%CI: 0.48-1.083, 
p=0.112). At 1 year bleeding rates of the two groups were similar. Adjusted outcomes and MACE free survival is shown in Figure 1.
conclusion: When compared to BMS, DES use in octogenarians and nonagenarians is safe and associated with lower TVR and MACE. 
